Free Trial

Afya Limited (NASDAQ:AFYA) Shares Bought by Doma Perpetual Capital Management LLC

Afya logo with Consumer Discretionary background

Doma Perpetual Capital Management LLC raised its holdings in shares of Afya Limited (NASDAQ:AFYA - Free Report) by 92.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 567,109 shares of the company's stock after purchasing an additional 272,200 shares during the quarter. Afya makes up 4.5% of Doma Perpetual Capital Management LLC's holdings, making the stock its 8th biggest position. Doma Perpetual Capital Management LLC owned about 0.61% of Afya worth $9,006,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Wellington Management Group LLP acquired a new position in shares of Afya in the fourth quarter valued at about $829,000. Renaissance Technologies LLC grew its position in shares of Afya by 14.0% during the 4th quarter. Renaissance Technologies LLC now owns 412,000 shares of the company's stock worth $6,543,000 after purchasing an additional 50,700 shares in the last quarter. State Street Corp grew its position in shares of Afya by 118.2% during the 3rd quarter. State Street Corp now owns 73,098 shares of the company's stock worth $1,248,000 after purchasing an additional 39,592 shares in the last quarter. Teacher Retirement System of Texas bought a new position in shares of Afya during the fourth quarter worth approximately $329,000. Finally, JPMorgan Chase & Co. raised its position in shares of Afya by 2,115.9% in the fourth quarter. JPMorgan Chase & Co. now owns 6,670 shares of the company's stock valued at $106,000 after buying an additional 6,369 shares in the last quarter. 88.02% of the stock is owned by institutional investors.

Afya Price Performance

NASDAQ AFYA traded up $0.48 on Friday, hitting $18.58. 210,952 shares of the company's stock were exchanged, compared to its average volume of 122,537. The stock has a 50-day moving average of $17.52 and a 200-day moving average of $16.72. The stock has a market cap of $1.74 billion, a price-to-earnings ratio of 14.98, a P/E/G ratio of 0.29 and a beta of 0.66. Afya Limited has a 52 week low of $14.52 and a 52 week high of $20.06. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.51.

Afya Dividend Announcement

The firm also recently disclosed a -- dividend, which was paid on Friday, April 4th. Investors of record on Wednesday, March 26th were given a dividend of $0.232 per share. The ex-dividend date of this dividend was Wednesday, March 26th. Afya's dividend payout ratio is currently 17.69%.

Analyst Ratings Changes

A number of brokerages recently issued reports on AFYA. JPMorgan Chase & Co. reduced their price target on Afya from $25.00 to $20.50 and set a "neutral" rating on the stock in a research report on Friday, January 17th. Morgan Stanley lowered Afya from an "equal weight" rating to an "underweight" rating and reduced their target price for the stock from $19.00 to $17.00 in a report on Tuesday, March 11th. Finally, Citigroup reaffirmed a "sell" rating and issued a $15.00 price target (down previously from $18.00) on shares of Afya in a research note on Friday, January 31st. Three equities research analysts have rated the stock with a sell rating and two have given a hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Reduce" and an average price target of $17.60.

View Our Latest Report on Afya

Afya Profile

(Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Recommended Stories

Institutional Ownership by Quarter for Afya (NASDAQ:AFYA)

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines